Latest filing published 23 Jan 2023 for Aura Biosciences, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Cadmus Rich: trading record in brief
Cadmus Rich, listed as board member, appears in our data through filings on Aura Biosciences, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 28 October 2021 and the latest from 19 January 2023.
The open-market record consists of 1 sale worth €21k, with no purchase. Outside the open market, there are 2 share grants.
The record was last updated on 23 January 2023 with a share grant in Aura Biosciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Cadmus Rich
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 34,125 shares0Common StockSEC:0000899243-23-002433:0
- 1,672 shares@ US$12.4481100.0% of flowCommon StockSEC:0000899243-22-034837:0
- 26,250 shares0Common StockSEC:0000899243-21-042094:0
3 of 3 declarations
